Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| IMMUCELL CORP /DE/ICCC · Entity 6837 | Director | April 15, 2026 | April 16, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
IMMUCELL CORP /DE/
Report date April 15, 2026 · Filed April 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Non Qualified Stock Options (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.60 · Expires 2036-04-15 | Direct | 11,933 |
Reported balance
After 2026-04-15 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-04-15 · Grant · Acquired 11,933 · Balance 11,933 F1: The stock option vests as follows: 3,977 shares becoming exercisable on each of April 15, 2027 and April 15, 2028, and 3,979 shares becoming exercisable on April 15, 2029. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock option vests as follows: 3,977 shares becoming exercisable on each of April 15, 2027 and April 15, 2028, and 3,979 shares becoming exercisable on April 15, 2029.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 15, 2026 Filed Apr 16, 2026 20:02 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | GrantNon Qualified Stock Options (Right to buy) · Derivative | 11,933 | $0.00 Strike: $7.60 | $0.00 |
DisclosureSEC source: 0001437749-26-012557 · rdgdoc.xml · derivative · entry 1 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,933 Underlying: Common Stock · 11,933 shares Expires 2036-04-15 F1 · derivative.exercise_date: The stock option vests as follows: 3,977 shares becoming exercisable on each of April 15, 2027 and April 15, 2028, and 3,979 shares becoming exercisable on April 15, 2029. Read SEC document |
| November 25, 2025 Filed Nov 28, 2025 13:12 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | PurchaseCommon Stock $0.10 par value per share | 1,633 | $4.77 | $7,781.25 |
DisclosureSEC source: 0001437749-25-036477 · rdgdoc.xml · nonDerivative · entry 2 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 4,740 Read SEC document |
| November 25, 2025 Filed Nov 28, 2025 13:12 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | PurchaseCommon Stock $0.10 par value per share | 1,633 | $4.76 | $7,773.08 |
DisclosureSEC source: 0001437749-25-036477 · rdgdoc.xml · nonDerivative · entry 1 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,720 Read SEC document |
| April 16, 2025 Filed Apr 14, 2026 19:38 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | GrantNon Qualified Stock Options (Right to buy) · Derivative | 10,000 | $0.00 Strike: $5.49 | $0.00 |
DisclosureSEC source: 0001437749-26-012236 · rdgdoc.xml · derivative · entry 1 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-04-16 Read SEC document |
| September 20, 2024 Filed Sep 24, 2024 12:30 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | GrantNon Qualified Stock Options (Right to buy) · Derivative | 10,000 | $3.60 Strike: $3.60 | $36,000.00 |
DisclosureSEC source: 0001213900-24-081207 · marketforms-67041.xml · derivative · entry 1 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-09-20 Read SEC document |
| August 28, 2024 Filed Aug 30, 2024 16:25 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | Disposition to issuerCommon stock $0.10 per value per share | 2,186 | $3.55 | $7,760.30 |
DisclosureSEC source: 0001213900-24-074326 · marketforms-66862.xml · nonDerivative · entry 1 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,797 F1 · balance_after: (1) This figure includes 6,987 shares of common stock held by immediate family members of Dr. Tomsche. Read SEC document |
| August 23, 2024 Filed Aug 26, 2024 19:00 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | Disposition to issuerCommon stock $0.10 per value per share | 6,005 | $3.55 | $21,317.75 |
DisclosureSEC source: 0001213900-24-072552 · marketforms-66848.xml · nonDerivative · entry 1 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129,611 F1 · balance_after: (1) This figure includes 6,987 shares of common stock held by immediate family members of Dr. Tomsche. Read SEC document |
| August 22, 2024 Filed Aug 22, 2024 17:05 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | Disposition to issuerCommon stock $0.10 per value per share | 10,000 | $3.55 | $35,500.00 |
DisclosureSEC source: 0001213900-24-071759 · marketforms-66833.xml · nonDerivative · entry 1 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,606 F1 · balance_after: (1) This figure includes 6,987 shares of common stock held by immediate family members of Dr. Tomsche. Read SEC document |
| August 19, 2024 Filed Aug 19, 2024 17:04 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | Disposition to issuerCommon stock $0.10 per value per share | 3,172 | $3.67 | $11,641.24 |
DisclosureSEC source: 0001213900-24-070559 · marketforms-66793.xml · nonDerivative · entry 3 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,606 F1 · balance_after: 1. This figure includes 6,987 shares of common stock held by immediate family members of Dr. Tomsche. Read SEC document |
| August 16, 2024 Filed Aug 19, 2024 17:04 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | Disposition to issuerCommon stock $0.10 per value per share | 4,811 | $3.72 | $17,882.97 |
DisclosureSEC source: 0001213900-24-070559 · marketforms-66793.xml · nonDerivative · entry 2 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,434 Read SEC document |
| August 15, 2024 Filed Aug 19, 2024 17:04 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | Disposition to issuerCommon stock $0.10 per value per share | 2,017 | $3.57 | $7,194.64 |
DisclosureSEC source: 0001213900-24-070559 · marketforms-66793.xml · nonDerivative · entry 1 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,623 Read SEC document |
| September 06, 2023 Filed Sep 6, 2023 16:25 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | Disposition to issuerCommon stock $0.10 per value per share | 3,100 | $4.75 | $14,737.71 |
DisclosureSEC source: 0001213900-23-074246 · marketforms-62560.xml · nonDerivative · entry 1 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,606 F1 · balance_after: 1. This figure includes 6,987 shares of common stock held by immediate family members of Dr. Tomsche. Read SEC document |
| March 14, 2023 Filed Mar 15, 2023 19:13 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | Disposition to issuerCommon Stock, $0.10 per value per share | 100 | $5.44 | $544.00 |
DisclosureSEC source: 0001213900-23-020267 · marketforms-60805.xml · nonDerivative · entry 25 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,506 F1 · balance_after: 1. This figure includes 6,987 shares of common stock held by immediate family members of Dr. Tomsche. Read SEC document |
| March 14, 2023 Filed Mar 15, 2023 19:13 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | Disposition to issuerCommon Stock, $0.10 per value per share | 69 | $5.53 | $381.57 |
DisclosureSEC source: 0001213900-23-020267 · marketforms-60805.xml · nonDerivative · entry 24 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,406 Read SEC document |
| March 14, 2023 Filed Mar 15, 2023 19:13 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | Disposition to issuerCommon Stock, $0.10 per value per share | 100 | $5.53 | $553.00 |
DisclosureSEC source: 0001213900-23-020267 · marketforms-60805.xml · nonDerivative · entry 23 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,337 Read SEC document |
| March 14, 2023 Filed Mar 15, 2023 19:13 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | Disposition to issuerCommon Stock, $0.10 per value per share | 69 | $5.53 | $381.57 |
DisclosureSEC source: 0001213900-23-020267 · marketforms-60805.xml · nonDerivative · entry 22 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,237 Read SEC document |
| March 14, 2023 Filed Mar 15, 2023 19:13 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | Disposition to issuerCommon Stock, $0.10 per value per share | 31 | $5.53 | $171.43 |
DisclosureSEC source: 0001213900-23-020267 · marketforms-60805.xml · nonDerivative · entry 21 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,168 Read SEC document |
| March 14, 2023 Filed Mar 15, 2023 19:13 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | Disposition to issuerCommon Stock, $0.10 per value per share | 31 | $5.53 | $171.43 |
DisclosureSEC source: 0001213900-23-020267 · marketforms-60805.xml · nonDerivative · entry 20 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,137 Read SEC document |
| March 14, 2023 Filed Mar 15, 2023 19:13 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | Disposition to issuerCommon Stock, $0.10 per value per share | 69 | $5.53 | $381.57 |
DisclosureSEC source: 0001213900-23-020267 · marketforms-60805.xml · nonDerivative · entry 19 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,106 Read SEC document |
| March 14, 2023 Filed Mar 15, 2023 19:13 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | Disposition to issuerCommon Stock, $0.10 per value per share | 31 | $5.53 | $171.43 |
DisclosureSEC source: 0001213900-23-020267 · marketforms-60805.xml · nonDerivative · entry 18 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,037 Read SEC document |
| March 14, 2023 Filed Mar 15, 2023 19:13 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | Disposition to issuerCommon Stock, $0.10 per value per share | 69 | $5.53 | $381.57 |
DisclosureSEC source: 0001213900-23-020267 · marketforms-60805.xml · nonDerivative · entry 17 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,006 Read SEC document |
| March 14, 2023 Filed Mar 15, 2023 19:13 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | Disposition to issuerCommon Stock, $0.10 per value per share | 31 | $5.53 | $171.43 |
DisclosureSEC source: 0001213900-23-020267 · marketforms-60805.xml · nonDerivative · entry 16 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,937 Read SEC document |
| March 14, 2023 Filed Mar 15, 2023 19:13 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | Disposition to issuerCommon Stock, $0.10 per value per share | 69 | $5.53 | $381.57 |
DisclosureSEC source: 0001213900-23-020267 · marketforms-60805.xml · nonDerivative · entry 15 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,906 Read SEC document |
| March 14, 2023 Filed Mar 15, 2023 19:13 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | Disposition to issuerCommon stock $0.10 per value per share | 100 | $5.53 | $553.00 |
DisclosureSEC source: 0001213900-23-020267 · marketforms-60805.xml · nonDerivative · entry 14 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,837 Read SEC document |
| March 14, 2023 Filed Mar 15, 2023 19:13 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | Disposition to issuerCommon Stock, $0.10 per value per share | 831 | $5.47 | $4,545.57 |
DisclosureSEC source: 0001213900-23-020267 · marketforms-60805.xml · nonDerivative · entry 13 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,737 Read SEC document |
| March 14, 2023 Filed Mar 15, 2023 19:13 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | Disposition to issuerCommon Stock, $0.10 per value per share | 309 | $5.50 | $1,699.50 |
DisclosureSEC source: 0001213900-23-020267 · marketforms-60805.xml · nonDerivative · entry 12 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,906 Read SEC document |
| March 14, 2023 Filed Mar 15, 2023 19:13 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | Disposition to issuerCommon Stock, $0.10 per value per share | 71 | $5.50 | $390.50 |
DisclosureSEC source: 0001213900-23-020267 · marketforms-60805.xml · nonDerivative · entry 11 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,597 Read SEC document |
| March 13, 2023 Filed Mar 15, 2023 19:13 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | Disposition to issuerCommon Stock, $0.10 per value per share | 100 | $5.24 | $524.00 |
DisclosureSEC source: 0001213900-23-020267 · marketforms-60805.xml · nonDerivative · entry 10 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,526 Read SEC document |
| March 13, 2023 Filed Mar 15, 2023 19:13 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | Disposition to issuerCommon Stock, $0.10 per value per share | 100 | $5.24 | $524.00 |
DisclosureSEC source: 0001213900-23-020267 · marketforms-60805.xml · nonDerivative · entry 9 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,426 Read SEC document |
| March 13, 2023 Filed Mar 15, 2023 19:13 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | Disposition to issuerCommon Stock, $0.10 per value per share | 10 | $5.23 | $52.30 |
DisclosureSEC source: 0001213900-23-020267 · marketforms-60805.xml · nonDerivative · entry 8 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,326 Read SEC document |
| March 13, 2023 Filed Mar 15, 2023 19:13 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | Disposition to issuerCommon Stock, $0.10 per value per share | 7 | $5.24 | $36.68 |
DisclosureSEC source: 0001213900-23-020267 · marketforms-60805.xml · nonDerivative · entry 7 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,316 Read SEC document |
| March 13, 2023 Filed Mar 15, 2023 19:13 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | Disposition to issuerCommon Stock, $0.10 per value per share | 3 | $5.24 | $15.72 |
DisclosureSEC source: 0001213900-23-020267 · marketforms-60805.xml · nonDerivative · entry 6 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,309 Read SEC document |
| March 13, 2023 Filed Mar 15, 2023 19:13 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | Disposition to issuerCommon Stock, $0.10 per value per share | 80 | $5.34 | $427.20 |
DisclosureSEC source: 0001213900-23-020267 · marketforms-60805.xml · nonDerivative · entry 5 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,306 Read SEC document |
| March 13, 2023 Filed Mar 15, 2023 19:13 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | Disposition to issuerCommon Stock, $0.10 per value per share | 900 | $5.37 | $4,833.00 |
DisclosureSEC source: 0001213900-23-020267 · marketforms-60805.xml · nonDerivative · entry 4 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,226 Read SEC document |
| March 13, 2023 Filed Mar 15, 2023 19:13 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | Disposition to issuerCommon Stock, $0.10 per value per share | 200 | $5.25 | $1,050.00 |
DisclosureSEC source: 0001213900-23-020267 · marketforms-60805.xml · nonDerivative · entry 3 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,326 Read SEC document |
| March 13, 2023 Filed Mar 15, 2023 19:13 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | Disposition to issuerCommon Stock, $0.10 per value per share | 300 | $5.24 | $1,572.00 |
DisclosureSEC source: 0001213900-23-020267 · marketforms-60805.xml · nonDerivative · entry 2 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,126 Read SEC document |
| March 13, 2023 Filed Mar 15, 2023 19:13 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | Disposition to issuerCommon Stock, $0.10 per value per share | 400 | $5.20 | $2,080.00 |
DisclosureSEC source: 0001213900-23-020267 · marketforms-60805.xml · nonDerivative · entry 1 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,826 Read SEC document |
| December 15, 2022 Filed Jan 24, 2023 23:27 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | GrantNon Qualified Stock Options (Right to buy) · Derivative | 10,000 | $6.52 Strike: $6.52 | $65,200.00 |
DisclosureSEC source: 0001213900-23-004913 · ownership.xml · derivative · entry 1 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2027-12-15 Read SEC document |
| September 12, 2022 Filed Sep 12, 2022 20:35 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | Disposition to issuerCommon Stock, $0.10 per value per share | 195 | $7.80 | $1,521.00 |
DisclosureSEC source: 0001213900-22-055334 · doc4.xml · nonDerivative · entry 11 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,426 F1 · balance_after: (1) This figure includes 6,987 shares of common stock held by immediate family members of Dr. Tomsche. Read SEC document |
| September 12, 2022 Filed Sep 12, 2022 20:35 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | Disposition to issuerCommon Stock, $0.10 per value per share | 606 | $7.75 | $4,696.50 |
DisclosureSEC source: 0001213900-22-055334 · doc4.xml · nonDerivative · entry 10 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,231 Read SEC document |
| September 09, 2022 Filed Sep 12, 2022 20:35 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | Disposition to issuerCommon Stock, $0.10 per value per share | 20 | $7.70 | $154.00 |
DisclosureSEC source: 0001213900-22-055334 · doc4.xml · nonDerivative · entry 9 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,625 Read SEC document |
| September 09, 2022 Filed Sep 12, 2022 20:35 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | Disposition to issuerCommon Stock, $0.10 per value per share | 33 | $7.80 | $257.40 |
DisclosureSEC source: 0001213900-22-055334 · doc4.xml · nonDerivative · entry 8 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,605 Read SEC document |
| September 09, 2022 Filed Sep 12, 2022 20:35 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | Disposition to issuerCommon Stock, $0.10 per value per share | 647 | $7.76 | $5,020.72 |
DisclosureSEC source: 0001213900-22-055334 · doc4.xml · nonDerivative · entry 7 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,572 Read SEC document |
| September 08, 2022 Filed Sep 12, 2022 20:35 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | Disposition to issuerCommon Stock, $0.10 per value per share | 1 | $7.62 | $7.62 |
DisclosureSEC source: 0001213900-22-055334 · doc4.xml · nonDerivative · entry 6 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,925 Read SEC document |
| September 08, 2022 Filed Sep 12, 2022 20:35 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | Disposition to issuerCommon Stock, $0.10 per value per share | 260 | $7.69 | $1,999.40 |
DisclosureSEC source: 0001213900-22-055334 · doc4.xml · nonDerivative · entry 5 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,924 Read SEC document |
| September 08, 2022 Filed Sep 12, 2022 20:35 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | Disposition to issuerCommon Stock, $0.10 per value per share | 5 | $7.70 | $38.50 |
DisclosureSEC source: 0001213900-22-055334 · doc4.xml · nonDerivative · entry 4 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,664 Read SEC document |
| September 08, 2022 Filed Sep 12, 2022 20:35 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | Disposition to issuerCommon Stock, $0.10 per value per share | 5 | $7.72 | $38.60 |
DisclosureSEC source: 0001213900-22-055334 · doc4.xml · nonDerivative · entry 3 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,659 Read SEC document |
| September 08, 2022 Filed Sep 12, 2022 20:35 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | Disposition to issuerCommon Stock, $0.10 per value per share | 329 | $7.71 | $2,536.59 |
DisclosureSEC source: 0001213900-22-055334 · doc4.xml · nonDerivative · entry 2 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,654 Read SEC document |
| September 08, 2022 Filed Sep 12, 2022 20:35 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | Disposition to issuerCommon Stock, $0.10 per value per share | 306 | $7.68 | $2,350.08 |
DisclosureSEC source: 0001213900-22-055334 · doc4.xml · nonDerivative · entry 1 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,325 Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 16:57 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | Disposition to issuerCommon stock $0.10 per value per share | 400 | $8.25 | $3,300.00 |
DisclosureSEC source: 0001213900-22-033261 · doc4.xml · nonDerivative · entry 19 Tomsche David Scott · CIK 0001384044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,019 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.